Yarrow Bioscience, Inc.
Nasdaq YARW · New Haven, CT
Works in Immunology · Metabolic & endocrine · Ophthalmology
Yarrow Bioscience, Inc. is a clinical trial sponsor based in New Haven, CT, listed as Nasdaq YARW. It has 1 active clinical trial with 232 planned participants, in Immunology, Metabolic & endocrine and Ophthalmology.
Trial track record · since 2021
Financials · Nasdaq YARW
Fundraising
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
On the market · 0 products
No marketed products under this name.
Questions about Yarrow Bioscience, Inc
Yarrow Bioscience, Inc is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 232 planned participants, in Immunology, Metabolic & endocrine, Ophthalmology. Since 2021 it has completed 0 trials and stopped 0 early.
Yarrow Bioscience, Inc is based in New Haven, CT and is listed as Nasdaq YARW. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Yarrow Bioscience, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-05.
Products come from FDA's drug application database and, for vaccines, cell and gene therapies and blood products, FDA's Purple Book of licensed biologics; checked 2026-09-28.
Approve Suite is not affiliated with Yarrow Bioscience, Inc.. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.